-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Text|Pharmaceutical Mission Hills
Recently, Insilico Medicine, an artificial intelligence drug research and development company, and Usynova announced a strategic cooperation
.
According to the agreement, the two parties will focus on unmet clinical needs in areas such as cancer and autoimmune diseases, combining the advantages of British Silicon’s end-to-end artificial intelligence drug discovery platform and the experience in the research and development of small molecule innovative drugs by Usenjianheng, and explore new Target discovery and druggability research, carry out compound screening, design and synthesis for difficult drug targets, and accelerate the development of small molecule innovative drugs
(The original text has been deleted)